Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Hepatol. May 27, 2025; 17(5): 104041
Published online May 27, 2025. doi: 10.4254/wjh.v17.i5.104041
Table 2 Univariate and multivariate Cox regression analysis of prognostic factors in the entire cohort and hepatitis B virus-hepatitis C virus infection status subgroups
Variables
Univariate HR (95%CI)
Univariate P
Multivariate HR (95%CI)
Multivariate P value
Demographic features
Sex1.2080.243
Age1.0010.851
Clinical features
Tumor size1.130< 0.0011.059 (1.024-1.094)0.001
Tumor number
    1< 0.001
    20.426< 0.001
    ≥ 30.407< 0.001
Ruptured tumor3.233< 0.001
Solid tumor0.342< 0.001
Intrahepatic vascular invasion3.2950.001
Extrahepatic vascular invasion9.8600.023
Portal thrombosis4.305< 0.0011.905 (1.393-2.608)< 0.001
Metastasis1.493< 0.0011.270 (1.069-1.509)0.007
Ascites3.406< 0.0011.560 (1.166-2.084)0.003
Portal hypertension1.3160.036
Cirrhosis1.938< 0.001
ECOG score3.731< 0.0012.801 (2.308-3.401)< 0.001
HBV-HCV infection status0.002
    HCV0.571< 0.001
    Non-B-non-C0.5890.001
    Co-infected0.8180.611
Laboratory examinations
    AFP 1.001< 0.0011.000 (1.000-1.000)0.020
    ALT 1.0000.538
    AST 1.002< 0.0011.001 (1.000-1.002)0.021
    Albumin0.917< 0.0010.956 (0.936-0.977)< 0.001
    PT0.982< 0.001
    INR0.9230.632
    Platelet count1.003< 0.001
    Total bilirubin1.005< 0.001
    Creatinine1.0030.113
Treatment
    RFA/WMA< 0.001
    Surgery0.064< 0.001
    TACE0.051< 0.001
    Chemotherapy0.123< 0.001
    Palliative care0.119< 0.001